Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060

European Heart Journal

Volumn 34, Issue 35, 2013, Pages 2746-2751

  Krijthe, Bouwe P ^a,b   Kunst, Anton ^c   Benjamin, Emelia J ^d,e,f   Lip, Gregory Y H ^g   Franco, Oscar H ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a,b   Stricker, Bruno H ^a,b,h   Heeringa, Jan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Netherlands Consortium for Healthy Aging ^*  (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d FRAMINGHAM HEART STUDY   (United States)

^e BOSTON UNIVERSITY   (United States)

^f BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h Inspectorate of Health Care   (Netherlands)

Author keywords

Atrial fibrillation; Epidemiology

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; EUROPEAN UNION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

ATRIAL FIBRILLATION; EPIDEMIOLOGY;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 84890100326     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht280     Document Type: Article

References (39)

1. Eurostat. The Europop2010 (Eurostat Population Projections 2010-based) convergence scenario contains statistical information on population projections at national level
2. Brinks R, Tamayo T, Kowall B, Rathmann W. Prevalence of type 2 diabetes in Germany in 2040: Estimates from an epidemiological model. Eur J Epidemiol 2012; 27:791-797
3. Mura T, Dartigues JF, Berr C. How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050. Eur J Neurol 2010;17:252-259
4. Stefansdottir H, Aspelund T, Gudnason V, Arnar DO. Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace 2011;13: 1110-1117
5. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, Maywald U, Bauersachs R, Breithardt G. Incidence and prevalence of atrial fibrillation: An analysis based on 8.3 million patients. Europace 2013;15:486-493
6. Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, Carolei A. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: Results from a population-based study. Stroke 2005;36:1115-1119
7. Ott A, Breteler MM, de Bruyne MC, van Harskamp F, Grobbee DE, HofmanA. Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. Stroke 1997;28:316-321
8. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003;107:2920-2925
9. Stewart S, Hart CL, Hole DJ, McMurray JJ.Apopulation-based study of the long-Term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002;113:359-364
10. Miyasaka Y, Barnes ME, Bailey KR, Cha SS, Gersh BJ, Seward JB, Tsang TS. Mortality trends in patients diagnosed with first atrial fibrillation: A 21-year community-based study. J Am Coll Cardiol 2007;49:986-992
11. Ringborg A, Nieuwlaat R, Lindgren P, Jonsson B, Fidan D, Maggioni AP, Lopez-Sendon J, Stepinska J, Cokkinos DV, Crijns HJ. Costs of atrial fibrillation in five European countries: Results from the Euro Heart Survey on atrial fibrillation. Europace 2008;10:403-411
12. Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, Kuipers EJ, Nijsten TE, Stricker BH, Tiemeier H, Uitterlinden AG, VernooijMW, Witteman JC. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol 2011;26: 657-686
13. Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, Mattace-Raso FU, Ziere G, Hofman A, Stricker BH, Witteman JC. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol 2012;27:173-185
14. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, Stijnen T, Lip GY, Witteman JC. Prevalence, incidence and lifetime risk of atrial fibrillation: The Rotterdam study. Eur Heart J 2006;27:949-953
15. Kors JA, van Herpen G, WuJ, ZhangZ, Prineas RJ, van Bemmel JH. Validation of anew computer program for Minnesota coding. J Electrocardiol 1996;29 (suppl):83-88
16. van Bemmel JH, Kors JA, van Herpen G. Methodology of the modular ECG analysis system MEANS. Methods Inf Med 1990;29:346-353
17. Halligan SC, Gersh BJ, BrownRDJr, Rosales AG, Munger TM, ShenWK, Hammill SC, Friedman PA. The natural history of lone atrial flutter. Ann Intern Med 2004;140: 265-268
18. Lelorier P, Humphries KH, Krahn A, Connolly SJ, Talajic M, Green M, Sheldon R, Dorian P, Newman D, Kerr CR, Yee R, Klein GJ. Prognostic differences between atrial fibrillation and atrial flutter. Am J Cardiol 2004;93:647-649
19. de Torbal A, Boersma E, Kors JA, van Herpen G, Deckers JW, van der Kuip DA, Stricker BH, Hofman A, Witteman JC. Incidence of recognized and unrecognized myocardial infarction in men and women aged 55 and older: The Rotterdam Study. Eur Heart J 2006;27:729-736
20. Remme WJ, Swedberg K, Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-1560
21. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence of heart failure and left ventricular dysfunction in the general population; The Rotterdam Study. Eur Heart J 1999;20:447-455
22. Wolf PA, Benjamin EJ, Belanger AJ, Kannel WB, Levy D, D'Agostino RB. Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J 1996;131:790-795
23. Friberg J, Scharling H, Gadsboll N, Jensen GB. Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). Am J Cardiol 2003;92: 1419-1423
24. DeWilde S, Carey IM, Emmas C, Richards N, Cook DG. Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart 2006;92:1064-1070
25. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: Its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012; 109:293-299
26. Bilato C, Corti MC, Baggio G, Rampazzo D, Cutolo A, Iliceto S, Crepaldi G. Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). Am J Cardiol 2009;104:1092-1097
27. Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess 2005;9:1-74
28. Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo Diet and Cancer study: A study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 2010;25:95-102
29. Ntaios G, Manios E, Synetou M, Savvari P, Vemmou A, Koromboki E, Saliaris M, Blanas K, Vemmos K. Prevalence of atrial fibrillation in Greece: The Arcadia Rural Study on Atrial Fibrillation. Acta Cardiol 2012;67:65-69
30. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: Analysis of data from the general practice research database. Heart 2001;86:284-288
31. Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: Implications for stroke prevention. Circulation 2013;127:930-937
32. GoAS, Hylek EM, Phillips KA, ChangY, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001;285:2370-2375
33. Gill PS, Calvert M, Davis R, Davies MK, Freemantle N, Lip GY. Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: The Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). PLoS ONE 2011;6:e26710
34. Marcus GM, Alonso A, Peralta CA, Lettre G, Vittinghoff E, Lubitz SA, Fox ER, Levitzky YS, Mehra R, Kerr KF, Deo R, Sotoodehnia N, Akylbekova M, Ellinor PT, Paltoo DN, Soliman EZ, Benjamin EJ, Heckbert SR, Candidate-Gene Association Resource Study. European ancestry as a risk factor for atrial fibrillation in AfricanAmericans. Circulation 2010;122:2009-2015
35. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence (vol 114, pg 119, 2006). Circulation 2006;114:E498-E498
36. NaccarelliGV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009;104:1534-1539
37. Heeringa J. Atrial fibrillation: Is the prevalence rising? Europace 2010;12:451-452
38. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 2013;362: 2155-2165
39. Blecker S, Paul M, Taksler G, Ogedegbe G, Katz S. Heart failure associated hospitalizations in the United States. J Am Coll Cardiol 2013;61:1259-1267